Our previous study has found that a higher frequency of MSI was detected in endometrial cancer than in ovarian and cervical cancers (unpublished data), which could explain the presence of aberrant methylation of hMLH1 gene in endometrial cancer, but absence in cervical cancer and ovarian cancer. Here, MLH1 is linked to cervical cancer.